The RASSF1A tumor suppressor regulates XPA-mediated DNA repair

Molecular and Cellular Biology

Volumn 35, Issue 1, 2015, Pages 277-287

  Donninger, Howard ^a   Clark, Jennifer ^a   Rinaldo, Francesca ^a   Nelson, Nicholas ^b   Barnoud, Thibaut ^b   Lee Schmidt, M ^b   Hobbing, Katharine R ^a   Vos, Michele D ^c   Sils, Brian ^a   Clark, Geoffrey J ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; REPLICATION FACTOR A; XERODERMA PIGMENTOSUM GROUP A PROTEIN; RASSF1 PROTEIN, HUMAN; RASSF1 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN; XPA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEACETYLATION; DISEASE ASSOCIATION; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA PROTEIN COMPLEX; EMBRYO; EXCISION REPAIR; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NEOPLASM; PROTEIN ACETYLATION; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; COMET ASSAY; DNA REPAIR; GENE EXPRESSION REGULATION; HEK293 CELL LINE; KNOCKOUT MOUSE; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICE; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; REPLICATION PROTEIN A; TUMOR SUPPRESSOR PROTEINS; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 84920036593     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00202-14     Document Type: Article

References (53)

1. Friedberg EC, Wood RD, Walker GC, Schultz RA, Siede W, Ellenberger T. 2006. DNA repair and mutagenesis. ASM Press, Washington, DC.
2. Nouspikel T. 2009. DNA repair in mammalian cells: so DNA repair really is that important? Cell Mol Life Sci 66:965-967. http://dx.doi.org/10.1007/s00018-009-8734-1.
3. Larsson LG. 2011. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol 21:367-376. http://dx.doi.org/10.1016/j.semcancer.2011.10.005.
4. Reinhardt HC, Schumacher B. 2012. The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet 28:128-136. http://dx.doi.org/10.1016/j.tig.2011.12.002.
5. Roos WP, Kaina B. 2013. DNA damage-induced apoptosis: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 332:237-248. http://dx.doi.org/10.1016/j.canlet.2012.01.007.
6. Dammann R, Schagdarsurengin U, Seidel C, Strunnikova M, Rastetter M, Baier K, Pfeifer GP. 2005. The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol 20:645-663.
7. Donninger H, Vos MD, Clark GJ. 2007. The RASSF1A tumor suppressor. J Cell Sci 120:3163-3172. http://dx.doi.org/10.1242/jcs.010389.
8. van der Weyden L, Adams DJ. 2007. The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 1776:58-85. http://dx.doi.org/10.1016/j.bbcan.2007.06.003.
9. Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark WM, Wilczynski SP, Li J, You M, Pfeifer GP. 2005. Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65:92-98.
10. Guo C, Tommasi S, Liu L, Yee JK, Dammann R, Pfeifer GP. 2007. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol 17:700-705. http://dx.doi.org/10.1016/j.cub.2007.02.055.
11. Hamilton G, Yee KS, Scrace S, O'Neill E. 2009. ATM regulates a RASSF1A-dependent DNA damage response. Curr Biol 19:2020-2025. http://dx.doi.org/10.1016/j.cub.2009.10.040.
12. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. 2000. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 275:35669-35672. http://dx.doi.org/10.1074/jbc. C000463200.
13. Matallanas D, Romano D, Al-Mulla F, O'Neill E, Al-Ali W, Crespo P, Doyle B, Nixon C, Sansom O, Drosten M, Barbacid M, Kolch W. 2011. Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. Mol Cell 44:893-906. http://dx.doi.org/10.1016/j.molcel.2011.10.016.
14. Jones CJ, Wood RD. 1993. Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA. Biochemistry 32:12096-12104. http://dx.doi.org/10.1021/bi00096a021.
15. Camenisch U, Nageli H. 2008. XPA gene, its product and biological roles. Adv Exp Med Biol 637:28-38. http://dx.doi.org/10.1007/978-0-387-09599-8_4.
16. Fan W, Luo J. 2010. SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Mol Cell 39:247-258. http://dx.doi.org/10.1016/j.molcel.2010.07.006.
17. Wu X, Shell SM, Yang Z, Zou Y. 2006. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation. Cancer Res 66:2997-3005. http://dx.doi.org/10.1158/0008-5472.CAN-05-3403.
18. Cleaver JE. 2005. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5:564-573. http://dx.doi.org/10.1038/nrc1652.
19. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. 2000. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25:315-319. http://dx.doi.org/10.1038/77083.
20. Donninger H, Barnoud T, Nelson N, Kassler S, Clark J, Cummins TD, Powell DW, Nyante SJ, Millikan RC, Clark GJ. 2011. RASSF1A and the rs2073498 cancer associated SNP. Front Oncol 1:54. http://dx.doi.org/10.3389/fonc.2011.00054.
21. Vos MD, Dallol A, Eckfeld K, Allen NP, Donninger H, Hesson LB, Calvisi D, Latif F, Clark GJ. 2006. The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem 281:4557-4563. http://dx.doi.org/10.1074/jbc. M512128200.
22. Konca K, LankoffA, Banasik A, Lisowska H, Kuszewski T, Gozdz S, Koza Z, Wojcik A. 2003. A cross-platform public domain PC imageanalysis program for the comet assay. Mutat Res 534:15-20. http://dx.doi.org/10.1016/S1383-5718(02)00251-6.
23. de Vries A, van Steeg H. 1996. Xpa knockout mice. Semin Cancer Biol 7:229-240. http://dx.doi.org/10.1006/scbi.1996.0031.
24. Berg RJ, de Vries A, van Steeg H, de Gruijl FR. 1997. Relative susceptibilities of XPA knockout mice and their heterozygous and wild-type littermates to UVB-induced skin cancer. Cancer Res 57:581-584.
25. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39-85. http://dx.doi.org/10.1146/annurev.biochem.73.011303.073723.
26. Zou L, Elledge SJ. 2003. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542-1548. http://dx.doi.org/10.1126/science.1083430.
27. El-Kalla M, Onyskiw C, Baksh S. 2010. Functional importance of RASSF1A microtubule localization and polymorphisms. Oncogene 29:5729-5740. http://dx.doi.org/10.1038/onc.2010.316.
28. Gao B, Xie XJ, Huang C, Shames DS, Chen TT, Lewis CM, Bian A, Zhang B, Olopade OI, Garber JE, Euhus DM, Tomlinson GE, Minna JD. 2008. RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res 68:22-25. http://dx.doi.org/10.1158/0008-5472.CAN-07-5183.
29. Yee KS, Grochola L, Hamilton G, Grawenda A, Bond EE, Taubert H, Wurl P, Bond GL, O'Neill E. 2012. A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma. Cancer Res 72:2206-2217. http://dx.doi.org/10.1158/0008-5472.CAN-11-2906.
30. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. 2002. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22:4309-4318. http://dx.doi.org/10.1128/MCB.22.12.4309-4318.2002.
31. Dallol A, Agathanggelou A, Fenton SL, Ahmed-Choudhury J, Hesson L, Vos MD, Clark GJ, Downward J, Maher ER, Latif F. 2004. RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res 64:4112-4116. http://dx.doi.org/10.1158/0008-5472.CAN-04-0267.
32. Liu L, Tommasi S, Lee DH, Dammann R, Pfeifer GP. 2003. Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22:8125-8136. http://dx.doi.org/10.1038/sj.onc.1206984.
33. Vos MD, Martinez A, Elam C, Dallol A, Taylor BJ, Latif F, Clark GJ. 2004. A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 64:4244-4250. http://dx.doi.org/10.1158/0008-5472.CAN-04-0339.
34. Hass CS, Lam K, Wold MS. 2012. Repair-specific functions of replication protein A. J Biol Chem 287:3908-3918. http://dx.doi.org/10.1074/jbc. M111.287441.
35. Gilljam KM, Muller R, Liabakk NB, Otterlei M. 2012. Nucleotide excision repair is associated with the replisome and its efficiency depends on a direct interaction between XPA and PCNA. PLoS One 7:e49199. http://dx.doi.org/10.1371/journal.pone.0049199.
36. Liu Y, Wang Y, Rusinol AE, Sinensky MS, Liu J, Shell SM, Zou Y. 2008. Involvement of xeroderma pigmentosum group A (XPA) in progeria arising from defective maturation of prelamin A. FASEB J 22:603-611.
37. Coin F, Oksenych V, Mocquet V, Groh S, Blattner C, Egly JM. 2008. Nucleotide excision repair driven by the dissociation of CAK from TFIIH. Mol Cell 31:9-20. http://dx.doi.org/10.1016/j.molcel.2008.04.024.
38. de Laat WL, Jaspers NG, Hoeijmakers JH. 1999. Molecular mechanism of nucleotide excision repair. Genes Dev 13:768-785. http://dx.doi.org/10.1101/gad.13.7.768.
39. Li L, Lu X, Peterson CA, Legerski RJ. 1995. An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol Cell Biol 15:5396-5402.
40. Saijo M, Takedachi A, Tanaka K. 2011. Nucleotide excision repair by mutant xeroderma pigmentosum group A (XPA) proteins with deficiency in interaction with RPA. J Biol Chem 286:5476-5483. http://dx.doi.org/10.1074/jbc. M110.172916.
41. Shell SM, Li Z, Shkriabai N, Kvaratskhelia M, Brosey C, Serrano MA, Chazin WJ, Musich PR, Zou Y. 2009. Checkpoint kinase ATR promotes nucleotide excision repair of UV-induced DNA damage via physical interaction with xeroderma pigmentosum group A. J Biol Chem 284:24213-24222. http://dx.doi.org/10.1074/jbc. M109.000745.
42. Donninger H, Allen N, Henson A, Pogue J, Williams A, Gordon L, Kassler S, Dunwell T, Latif F, Clark GJ. 2011. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions. J Biol Chem 286:18483-18491. http://dx.doi.org/10.1074/jbc. M110.214874.
43. Rapin I. 2013. Disorders of nucleotide excision repair. Handb Clin Neurol 113:1637-1650. http://dx.doi.org/10.1016/B978-0-444-59565-2.00032-0.
44. Ricceri F, Porcedda P, Allione A, Turinetto V, Polidoro S, Guarrera S, Rosa F, Voglino F, Pezzotti A, Minieri V, Accomasso L, Cibrario RE, Orlando L, Giachino C, Matullo G. 2011. Involvement of MRE11A and XPA gene polymorphisms in the modulation ofDNAdouble-strand break repair activity: a genotype-phenotype correlation study. DNA Repair (Amst) 10:1044-1050. http://dx.doi.org/10.1016/j.dnarep.2011.08.003.
45. Del Re DP, Matsuda T, Zhai P, Gao S, Clark GJ, Van Der Weyden L, Sadoshima J. 2010. Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. J Clin Invest 120:3555-3567. http://dx.doi.org/10.1172/JCI43569.
46. Mensah GA, Brown DW. 2007. An overview of cardiovascular disease burden in the United States. Health Aff(Millwood) 26:38-48. http://dx.doi.org/10.1377/hlthaff.26.1.38.
47. Yuan F, Xie Q, Wu J, Bai Y, Mao B, Dong Y, Bi W, Ji G, Tao W, Wang Y, Yuan Z. 2011. MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation. J Biol Chem 286:6940-6945. http://dx.doi.org/10.1074/jbc. M110.182543.
48. Marouco D, Garabadgiu AV, Melino G, Barlev NA. 2013. Lysinespecific modifications of p53: a matter of life and death? Oncotarget 4:1556-1571.
49. Arif M, Senapati P, Shandilya J, Kundu TK. 2010. Protein lysine acetylation in cellular function and its role in cancer manifestation. Biochim Biophys Acta 1799:702-716. http://dx.doi.org/10.1016/j.bbagrm.2010.10.002.
50. Li Z, Musich PR, Zou Y. 2011. Differential DNA damage responses in p53 proficient and deficient cells: cisplatin-induced nuclear import of XPA is independent of ATR checkpoint in p53-deficient lung cancer cells. Int J Biochem Mol Biol 2:138-145.
51. Del Re DP, Matsuda T, Zhai P, Maejima Y, Jain MR, Liu T, Li H, Hsu CP, Sadoshima J. 2014. Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL. Mol Cell 54:639-650. http://dx.doi.org/10.1016/j.molcel.2014.04.007.
52. Cho HJ, Jeong HG, Lee JS, Woo ER, Hyun JW, Chung MH, You HJ. 2002. Oncogenic H-Ras enhances DNA repair through the Ras/phosphatidylinositol 3-kinase/Rac1 pathway in NIH3T3 cells. Evidence for association with reactive oxygen species. J Biol Chem 277:19358-19366. http://dx.doi.org/10.1074/jbc. M200933200.
53. Tu Z, Aird KM, Bitler BG, Nicodemus JP, Beeharry N, Xia B, Yen TJ, Zhang R. 2011. Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibitDNArepair, and promote senescence. Dev Cell 21:1077-1091. http://dx.doi.org/10.1016/j.devcel.2011.10.010.